488 related articles for article (PubMed ID: 18695978)
1. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation.
Zanger UM; Turpeinen M; Klein K; Schwab M
Anal Bioanal Chem; 2008 Nov; 392(6):1093-108. PubMed ID: 18695978
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 in Pharmacogenetics: An Update.
Tornio A; Backman JT
Adv Pharmacol; 2018; 83():3-32. PubMed ID: 29801580
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 pharmacogenetics and cancer.
Rodriguez-Antona C; Ingelman-Sundberg M
Oncogene; 2006 Mar; 25(11):1679-91. PubMed ID: 16550168
[TBL] [Abstract][Full Text] [Related]
4. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
Sikka R; Magauran B; Ulrich A; Shannon M
Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomic protocols in CNS disorders and dementia.
Cacabelos R
Neurodegener Dis; 2010; 7(1-3):167-9. PubMed ID: 20197699
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics-guided dose modifications of antidepressants.
Seeringer A; Kirchheiner J
Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of the cytochromes P450.
Daly AK
Curr Top Med Chem; 2004; 4(16):1733-44. PubMed ID: 15579105
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of the major polymorphic metabolizing enzymes.
Daly AK
Fundam Clin Pharmacol; 2003 Feb; 17(1):27-41. PubMed ID: 12588628
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
Johansson I; Ingelman-Sundberg M
Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
11. Estimation of drug-metabolizing capacity by cytochrome P450 genotyping and expression.
Temesvári M; Kóbori L; Paulik J; Sárváry E; Belic A; Monostory K
J Pharmacol Exp Ther; 2012 Apr; 341(1):294-305. PubMed ID: 22262920
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 pharmacogenetics in drug development: in vitro studies and clinical consequences.
Rodrigues AD; Rushmore TH
Curr Drug Metab; 2002 Jun; 3(3):289-309. PubMed ID: 12083322
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
Lee IS; Kim D
Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
[TBL] [Abstract][Full Text] [Related]
14. Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions.
Vickers AE; Sinclair JR; Zollinger M; Heitz F; Glänzel U; Johanson L; Fischer V
Drug Metab Dispos; 1999 Sep; 27(9):1029-38. PubMed ID: 10460803
[TBL] [Abstract][Full Text] [Related]
15. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
16. The role of human CYP2C8 and CYP2C9 variants in pioglitazone metabolism in vitro.
Muschler E; Lal J; Jetter A; Rattay A; Zanger U; Zadoyan G; Fuhr U; Kirchheiner J
Basic Clin Pharmacol Toxicol; 2009 Dec; 105(6):374-9. PubMed ID: 19614891
[TBL] [Abstract][Full Text] [Related]
17. Identification of human cytochrome P450 and flavin-containing monooxygenase enzymes involved in the metabolism of lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist.
Usmani KA; Chen WG; Sadeque AJ
Drug Metab Dispos; 2012 Apr; 40(4):761-71. PubMed ID: 22266842
[TBL] [Abstract][Full Text] [Related]
18. Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function.
Uno Y; Iwasaki K; Yamazaki H; Nelson DR
Drug Metab Rev; 2011 Aug; 43(3):346-61. PubMed ID: 21303270
[TBL] [Abstract][Full Text] [Related]
19. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
[TBL] [Abstract][Full Text] [Related]
20. Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s.
McGinnity DF; Parker AJ; Soars M; Riley RJ
Drug Metab Dispos; 2000 Nov; 28(11):1327-34. PubMed ID: 11038161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
